Cancer Research Technology
Log in Register
Menu

Phosphatidylinositol-4-phosphate 5-kinase inhibitor PIP5K Small Molecule (Tool Compound)

Invented by Dr Martin Swarbrick from Cancer Research Horizons
Invented at Cancer Research Technology – AstraZeneca Metabolism Alliance Team

Info

Catalogue Number 160406
Antigen/Gene or Protein Targets Phosphatidylinositol-4-phosphate 5-kinase (PIP5K)
Synonyms Synonyms for Phosphatidylinositol-4-phosphate 5-kinase: PIKFYVE, Phosphoinositide Kinase, FYVE Finger Containing Phosphatidylinositol-3-Phosphate/Phosphatidylinositol 5-Kinase Type III, Phosphatidylinositol 3-Phosphate 5-Kinase Type III, Type III PIP Kinase, PIPkin-III, PIP5K3, FYVE Finger-Containing Phosphoinositide Kinase 4, 1-Phosphatidylinositol-3-Phosphate 5-Kinase, Phosphatidylinositol 3-Phosphate 5-Kinase, Zinc Finger FYVE Domain Containing, Epididymis Luminal Protein 37, FYVE Domain Containing 29, KIAA0981, ZFYVE29, PIKfyve, HEL37, PIP5K, FAB1, CFD
Type Inhibitor
Relevance A selective inhibitor of phosphatidylinositol-4-phosphate 5-kinase (PIP5K) which demonstrates anti-cancer activity. The PIP5K isoforms are PtdIns4P 5-kinases that endogenously synthesise the secondary messenger PtdIns(4,5)P2. PtdIns(4,5)P2 is involved in a wide variety of biological processes, including development, endocytosis, actin dynamics, chemotaxis, and Ins(1,4,5)P3 formation. The distinct subcellular localizations of these proteins indicate that specific PIP5K isoforms interact with particular components in a given subcellular compartment and produce function-specific pools of PtdIns(4,5)P2.

The PIP5K subfamily is known to be involved in diverse cellular functions including embryonic development via the Wnt pathway, endocytosis, regulation of the actin cytoskeleton, and chemotaxis via impairment of cellular polarization.
On Target IC50 PIP5Kα IC50: 0.011 µM
PIP5Kβ IC50: 0.004 µM
PIP5Kγ IC50: 0.001 µM
Selectivity PI4KCA IC50: 20.9 µM
PI4KCB IC50: 5.99 µM
PI3Kα IC50: 34.6 µM
Key Attributes Cell Permeability: Caco2 permeability: 4.49 x 10-6 cm/s (efflux ratio 3.3)

Molecular Weight: 430.5 kDa
Solubility 15 µM (Aqueous)
Research Area Cell Structure and Motility, Developmental Biology
Notes Relevant Indications: PI3K, PLC, Wnt, Fc-receptor, BAF

Negative Control Available: No

The compounds are made up to 12mM stock concentration in DMSO. The final concentration of DMSO when treating cells should be less than 1%.

References

There are 1 reference entries for this reagent.

View All References

References: 1 entry

Andrews et al. 2014. Eur. J. Cancer. 50(6):91


Add a reference

References: 1 entry

Andrews et al. 2014. Eur. J. Cancer. 50(6):91


Add a reference